Assignee
SYNEDGEN INC
US·17 granted patents·16 pending applications·41 citations·filing 2013–2024
Top patents by PatentIndex Score
33 records- 0194US9732164B2Chitosan-derivative compounds and methods of controlling microbial populationsSYNEDGEN INC·Filed 2015·Granted Aug 15, 2017·14 cites·19 claims
- 0291US2025345355A1Methods and compositions for treating wounds utilizing chitosan compoundsSYNEDGEN INC·Filed 2024·Application pending·0 cites
- 0389US9234050B2Chitosan derivatives to treat animals or optimize animal healthSYNEDGEN INC·Filed 2013·Granted Jan 12, 2016·12 cites·4 claims
- 0488US10716803B2Methods for treatment or prevention of damage resulting from radiation, trauma or shockSYNEDGEN INC·Filed 2018·Granted Jul 21, 2020·3 cites·15 claims
- 0587US11786547B2Methods and compositions for disrupting biofilm utilizing chitosan-derivative compoundsSYNEDGEN INC·Filed 2019·Granted Oct 17, 2023·2 cites·18 claims
- 0687US2024197769A1Methods and compositions for treating wounds utilizing chitosan compoundsSYNEDGEN INC·Filed 2023·Application pending·0 cites
- 0786US11957707B2Compositions and methods of use thereofSYNEDGEN INC·Filed 2019·Granted Apr 16, 2024·2 cites·19 claims
- 0885US10494451B2Chitosan-derivative compounds and methods of controlling microbial populationsSYNEDGEN INC·Filed 2017·Granted Dec 3, 2019·3 cites·11 claims
- 0982US12533375B2Compositions and methods of use thereofSYNEDGEN INC·Filed 2024·Granted Jan 27, 2026·0 cites·18 claims
- 1082US12465616B2Methods and compositions for disrupting biofilm utilizing chitosan-derivative compoundsSYNEDGEN INC·Filed 2023·Granted Nov 11, 2025·0 cites·19 claims
- 1182US10022393B2Methods for treatment or prevention of damage resulting from radiation, trauma or shockSYNEDGEN INC·Filed 2013·Granted Jul 17, 2018·4 cites·28 claims
- 1280US12594296B2Methods for treatment or prevention of damage resulting from radiation, trauma or shockSYNEDGEN INC·Filed 2024·Granted Apr 7, 2026·0 cites·11 claims
- 1380US11077135B2Derivatized chitosan polymers and methods of treating vascular disordersSYNEDGEN INC·Filed 2016·Granted Aug 3, 2021·1 cites·12 claims
- 1480US2025325579A1Compositions and methods of use for wound healingSYNEDGEN INC·Filed 2024·Application pending·0 cites
- 1579US2025025492A1Derivatized chitosan polymers and methods of treating vascular disordersSYNEDGEN INC·Filed 2024·Application pending·0 cites
- 1673US11911412B2Derivatized chitosan polymers and methods of treating vascular disordersSYNEDGEN INC·Filed 2021·Granted Feb 27, 2024·0 cites·16 claims
- 1773US2020299417A1Chitosan-derivative compounds and methods of controlling microbial populationsSYNEDGEN INC·Filed 2019·Application pending·0 cites
- 1872US2023181623A1Compositions and methods of use for wound healingSYNEDGEN INC·Filed 2022·Application pending·0 cites
- 1970US11975018B2Methods for treatment or prevention of damage resulting from radiation, trauma or shockSYNEDGEN INC·Filed 2021·Granted May 7, 2024·0 cites·19 claims
- 2068US11717532B2Methods and compositions for treating wounds utilizing chitosan compoundsSYNEDGEN INC·Filed 2018·Granted Aug 8, 2023·0 cites·19 claims
- 2163US2023021050A1Compositions and methods of their useSYNEDGEN INC·Filed 2022·Application pending·0 cites
- 2261US2016022564A1Oral formulation of polyglucosamine derivatives in combination with a non-fermentable sugarSYNEDGEN INC·Filed 2014·Application pending·0 cites
- 2360US10765616B2Oral formulation of polyglucosamine derivatives in combination with a non-fermentable sugarSYNEDGEN INC·Filed 2018·Granted Sep 8, 2020·0 cites·4 claims
- 2460US2020061192A1Derivatized polyglucosamines for delivery of small molecules, peptides, and proteinsSYNEDGEN INC·Filed 2019·Application pending·0 cites
- 2559US11433092B2Compositions and methods of use for wound healingSYNEDGEN INC·Filed 2014·Granted Sep 6, 2022·0 cites·18 claims
- 2656US12533374B2Compositions and methods of use thereofSYNEDGEN INC·Filed 2021·Granted Jan 27, 2026·0 cites·20 claims
- 2756US2015031610A1Derivatized polyglucosamines for delivery of small molecules, peptides, and proteinsSYNEDGEN INC·Filed 2013·Application pending·0 cites
- 2856US2015224044A1Oral care methods and compositions utilizing chitosan-derivative compoundsSYNEDGEN INC·Filed 2014·Application pending·0 cites
- 2954US2017136056A1Methods and compositions for disrupting biofilm utilizing chitosan-derivative compoundsSYNEDGEN INC·Filed 2017·Application pending·0 cites
- 3054US2019070214A1Compositions and methods of their useSYNEDGEN INC·Filed 2017·Application pending·0 cites
- 3154US2017119810A1Methods and compositions for treating wounds utilizing chitosan compoundsSYNEDGEN INC·Filed 2016·Application pending·0 cites
- 3251US2018049965A1Oral care methods and compositions utilizing chitosan-derivative compoundsSYNEDGEN INC·Filed 2017·Application pending·0 cites
- 3346US2017304355A1Compositions and methods of use thereofSYNEDGEN INC·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →